Article
Medtronic launches head-to-head TAVR study against Edwards - MassDevice
Rating:
0.0
Views:
155
Likes:
1
Library:
1
Medtronic (NYSE:MDT) today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS), primarily in women. The postmarket SMART trial will compare valve safety and performance of the self-expanding Medtronic Evolut PRO and PRO+TAVR Systems against Edwards Lifesciences' (NYSE:EW) balloon-expandable SAPIEN 3 and […]
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value